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We have previously demonstrated that human vaginal Lactobacillus crispatus 2029 
(LC2029) strain is highly adhesive to cervicovaginal epithelial cells, exhibits antagonistic 
activity against genitourinary pathogens and expresses surface-layer protein (Slp). The aims 
of the present study were elucidation of Slp structural and immunomodulatory characteristics 
and its roles in protective properties of the whole vaginal LC2029 bacteria against foodborne 
pathogens. Enteric Caco-2 and colon HT-29 cell lines were used as the in vitro models of the 
human intestinal epithelial layer. LC2029 strain has two homologous surface-layer (S-layer) 
genes, slp1 and slp2. Whilst we found no evidence for the expression of slp1 under the 
growth conditions used, a very high level of expression of the slp2 gene was detected. C-
terminal part of the amino sequence of Slp2 protein was found to be highly similar to that of 
the conserved C-terminal region of SlpA protein of L. crispatus  Zj001 isolated from pig 
intestines and CbsA protein of L. crispatus  JCM5810 isolated from chicken intestines, and 
was substantially variable at the N-terminal and middle regions. The amino acid sequence 
identity between SlpA and CbsA was as high as 84%, whilst the identity levels of these 
sequences with that of Slp2 were only 49% and 50% (respectively). LC2029 strain was found 
to be both acid and bile tolerant. Survival in simulated gastric and intestinal juices of LC2029 
cells unable to produce Slp2 was reduced by 2-3 logs. Vaginal L. crispatus 1385 (LC1385) 
strain not expressing Slp was also very sensitive to gastric and intestinal stresses. Slp2 was 
found to be non-covalently bound to the surface of the bacterium, acting as an adhesin and 
facilitating interaction of LC2029 lactobacilli with the host immature or fully differentiated 
Caco-2 cells, as well as HT-29 cells. No toxicity to or damage of Caco-2 or HT-29 epithelial 
cells were detected after 24 h of colonization by LC2029 lactobacilli. Both Slp2 protein and 
LC2029 cells induced NF-kB activation in Caco-2 and HT-29 cells, but did not induce 
expression of innate immunity mediators Il-8, Il-1β, and TNF-α. Slp2 and LC2029 inhibited 
Il-8 production in Caco-2 and HT-29 cells induced by MALP-2 and increased production of 
anti-inflammatory cytokine Il-6. Slp2 inhibited production of CXCL1 and RANTES by 
Caco-2 cells during differentiation and maturation process within 15 days. Culturing Caco-2 
and HT-29 cells in the presence of Slp2 increased adhesion of bifidobacteria BLI-2780 to 
these enterocytes. Upon binding to Caco-2 and HT-29 cells, Slp2 protein and LC2029 
lactobacilli were recognized by toll-like receptors (TLR) 2/6. It was shown that LC2029 
strain is a strong co-aggregator of foodborne pathogens Campylobacter jejuni, Salmonella 













ability of LC2029 to co-aggregate these enteropathogens. Slp2 and intact LC2029 lactobacilli 
inhibited foodborne pathogen-induced activation of caspase-9 and caspase-3 as apoptotic 
biomarkers in Caco-2 and HT-29 cells. In addition, Slp2 and Slp2-positive LC2029 strain 
reduced adhesion of tested pathogenic bacteria to Caco-2 and HT-29 cells. Slp2-positive 
LC2029 strain but not Slp2 alone provided bactericidal effect on foodborne pathogens. These 
results suggest a range of mechanisms involved in inhibition of growth, viability, and cell-
adhesion properties of pathogenic Proteobacteria by the Slp2 producing LC2029, which may 
be useful in treatment of necrotizing enterocolitis (NEC) in newborns and foodborne 
infectious diseases in children and adults, increasing the colonization resistance and 
maintaining the intestinal homeostasis. 
 
Key words: S- layer proteins, Lactobasilus crispatus, immunomodulation, antagonistic 
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Introduction   
Surface-layer proteins (Slps) form regular two-dimensional cell envelope structures found on 
archaea and many bacteria [1]. Bacterial surface layers are composed of single protein 
subunits and have significant strength, flexibility, and semi-permeability, resembling chain 
mail [2]. In archaea, they are involved in the maintenance of the cell shape and cell division 
[3]. In pathogenic bacteria, Slps, being the hot spots of evolution, where changes occur very 
quickly, provide effective adhesion to the host cells and are required for virulence [4,5]. 
Several but not all species of the genus Lactobacillus possess the S surface-layer (S-layer) 
[6]. Some lactobacilli are associated with the host mucosal surface, including the 
gastrointestinal tract (GIT) and urogenital tract [7]. Slps in these bacteria perform protective 
functions providing resistance of host tissues to colonization by the pathogenic 
microorganisms [8]. Slp sequence variability and functions in lactobacilli are not only 
species but also strain specific [9]. This is one of the reasons for significant strain differences 
in biological properties of lactobacilli. Healthy vaginal microbiota is dominated by 
Lactobacillus spp., which form a critical line of defense against genitourinary pathogens [10–
12]. The functions of vaginal lactobacilli are related to the maintenance of an environment 
that limits the growth of pathogens [13]. Different factors that increase the risk of bacterial 
vaginosis (BV), yeast vulvovaginal candidiasis (VVC), and urinary tract infections (UTIs) 













led to research on the strains and properties of vaginal lactobacilli, which may be responsible 
for the maintenance of a pathogen-free environment in the genitourinary tract. Healthy 
vaginal microbiota is typically dominated by Lactobacillus species such as L. iners, L. 
crispatus, L. jensenii, and L. gasseri [11,15]. L. crispatus appears to be substantially 
prevailing over the other hydrogen peroxide producing Lactobacillus species [16]. A type I 
microbiota with the dominance of the L. crispatus species is important for maintaining of 
healthy birth tract [11]. Vaginal colonization with probiotic human-derived L. crispatus  Slp-
positive strain CTV-05 has been successful [17]. Slp-positive L. crispatus LC2029 strain was 
isolated upon investigation of vaginal lactobacilli from healthy women of reproductive age 
and selected as probiotic candidate for prophylactics and treatment of genitourinary 
infections [18]. Our previous research showed that the Slp was involved in the homeostatic 
interactions with the cervicovaginal epithelial cells and participated in their effective 
colonization by vaginal LC2029 strain. S-layer was responsible for the high affinity binding 
of the LC2029 strain to type IV collagen as one of the main components of the extracellular 
matrix on cervical HeLa and vaginal VK2/E6E7 epithelial cells (Kd = (8.0±0.7)×10
-10 
M) 
[18]. Slp producing LC2029 strain provided wide spectrum of antagonistic activity increasing 
colonization resistance to genitourinary tract infections by BV and VVC associated 
pathogens [18]. In the same line, Verstraelen and colleagues  reported that vaginal strains L. 
crispatus promote stability of the normal vaginal microbiota in pregnancy [19]. 
Early bacterial populations of neonates depend on environmental factors, such as mode of 
delivery, formula feeding vs. breast feeding, and other [20]. During the birth of a full-term 
newborn, a small amount of the mother
’
s vaginal microbiota including L. crispatus  is 
naturally ingested and enters the GIT of neonates [21]. L. crispatus strain M247, showing a 
cell aggregation phenotype, was isolated from a fecal sample taken from a weaning baby. 
The strain adhered to ileal mucus and Caco-2 cells in vitro. Three human trials with M247 
were performed. M247 could be recovered from either fecal samples or biopsies taken from 
the colon [22]. However, very little is presently known about the role of vaginal L. crispatus 
strains, evolutionarily selected for dwelling in a vaginal microecological niche of healthy 
women, in the process of human intestinal homeostasis formation and protection of GIT 
against foodborne pathogens. The Slp producing L. crispatus  strains isolated from chicken 
and pig intestines were found to have antagonistic activity against foodborne pathogens [23–
25], but the effects of human vaginal L. crispatus  strains and their Slps on these pathogens 













Escherichia coli belonging to Proteobacteria are commonly involved in human infectious 
diseases [26]. It is known that in prematurely born children, the intestinal microbiota contains 
a high level of Proteobacteria responsible for necrotizing enterocolitis (NEC) [27]. S. 
enteritidis and C. jejuni carried by chickens, poultry and swine production, are the major 
sources of human intestinal infections. E. coli O157:H7 is also associated with human 
intestinal diseases [28,29]. In this work, we investigated the structural and 
immunomodulatory characteristics of Slp2 and its role in protective properties of whole 
LC2029 bacteria against foodborne pathogens. 
 
Materials and methods 
Bacterial strains and growth conditions  
L. crispatus 2029 (LC2029) Slp-positive strain was originally isolated from a vaginal smear 
of a healthy woman of reproductive age. The strain was deposited at the All-Russian 
Collection of Microorganisms at the G. K. Skryabin Institute of Biochemistry and Physiology 
of Microorganisms under the registration number VKM B-2727D. L. crispatus (LC1385) S-
layer negative strain was originally isolated from a vaginal smear of a woman of reproductive 
age with clinical diagnosis: recurrent VVC, had history of BV. These strains were grown in 
Man-Rogosa-Sharpe (MRS) broth or agar containing MRS plates (Himedia, India), 37°C in 
5% CO2 or anaerobically 48h. Bifidobacterium longum subsp. infantis (BLI-2780) strain was 
originally isolated from fecal sample of a healthy, full-term, breast-fed infant at 14 day of 
age. The strain was grown in MRS, 37°C anaerobically 48h. A complete list of 
microorganisms used in this study and their growth conditions is provided in Table 1. 
 
Transmission electron microscopy of thin sections 
Transmission electron microscopy (TEM) was performed as described in [18] with some 
modifications. Briefly, the LC2029 cells were prefixed with 1.5 % (v/v) glutaraldehyde 
solution in 0.05 M cacodylate buffer (pH 7.2) at 4°C for 1 h. After three washings with the 
same buffer, the cells were fixed with 1% OsO4 in 0.05 M cacodylate buffer at 20°C for 3h. 
After dehydration, the cells were embedded into epoxy resin Epon 812. Ultrathin sections 
were made on an 8800 ULTROTOME III (LKB, Sweden). The sections were mounted on 
copper grids covered with a Formvar film, contrasted with uranyl acetate for 30 min and 
stained with lead citrate [30] at 20°C for 5 min. The sections were investigated using a JEM-














Preparation of Slp, SDS-PAGE and Western blotting analysis 
Slp was extracted and purified according to [31]. Briefly, Slp was extracted from LC2029 
strain by 5 M LiCl. The extract was purified by chromatography on cation-exchange column. 
The purified Slp was examined by SDS-PAGE containing 12% polyacrylamide gel. Western 
blotting analysis was performed essentially as described in [32]. A synthetic peptide 
(YQVSNGKAVSQMPDQKAVVADVNA) corresponding to a unique amino acid sequence 
214-237 of Slp2 was synthesized. Additionally, C-terminal cysteine was included into the 
peptide for conjugation with keyhole limpet hemocyanin (KLH) through this additional 
residue. The peptide-carrier conjugate was purified by gel-filtration and used for the 
generation of mouse monoclonal anti-Slp2 antibodies that were used as “primary antibody” 
in Western blotting analysis. The Goat-Anti-Mouse-Poly-HRP (Pierce), 250 ng/ml in 5% 
milk were used as a secondary antibody. The SuperSignal West Pico Chemiluminescent 
Substrate (Pierce) and blue X-ray film (Phenix Research Products, USA) were used for 
visualization. The LC2029 cells with a depleted Slp2 were tested for tolerance to gastric and 
intestinal stresses, the ability to adhere to immature Caco-2 and HT-29 cells, co-aggregative 
and antagonistic activity to foodborne pathogens. 
 
Assays of acid and bile salt tolerance 
Determination of Lactobacillus strains tolerance to acid and bile salt was performed as 
described in [33] with a modification. Briefly, bacterial cultures (stationary phase) were 
grown in MRS medium, pH 6.5 for 48 h at 37°C, 10% CO2, harvested by centrifugation and 
washed twice with phosphate buffered saline (PBS), pH 7.4. The cell pellet were either 
resuspended in fresh MRS broth at pH 2.5 and maintained at 37°C for 10 min, 30 min and 60 
min for acid tolerance assay or, alternatively, resuspended in MRS broth followed by 
inoculation into heat-sterilized fresh swine bile and incubation at 37°C for 5 h. Acid and bile 
were absent in control samples. The viable cells from the cultures were enumerated on MRS 
agar incubated at 37°C for 48h. Each experiment was carried out in triplicate. 
 
Intestinal epithelial in vitro models 
Immortalized epithelial Caco-2 cells showing marked characteristics of human small 
intestine enterocytes and HT-29 cells showing marked characteristics of human large 













medium composed of Dulbecco's modified Eagle's medium (DMEM) with 10% heat-
inactivated fetal bovine serum, 1% nonessential amino acid, 1% glutamine. 25mM HEPES 
buffer. Cells were cultured at 37°C in a 5% CO2 in humidified atmosphere. Caco-2 cells and 
HT-29 cells reached confluency by 15 day, a time when morphological and functional 
differentiation is complete [34]. All cell lines used tested negative for mycoplasma. 
 
Measurement of epithelial cell viability 
Caco-2 and HT-29 cell viability was elucidated as described in [35]. Briefly, the CellTiter 96 
MTT [3-(4.5-dimethyl-2-thiazolyl)-2.5-diphenyl-2H- tetrazolium bromide] assay (Promega, 
Madison, WI) was used to assess epithelial cell viability of Caco-2 and HT-29 cells. In 
addition, the trypan blue assay was used for the enumeration of viable Caco-2 and HT-29 
cells after bacterial colonization. 
 
NF-kB luciferase assay 
Caco-2 and HT-29 cells were transfected with pHTS-NF-kB firefly luciferase reporter vector 
(Biomyx Technology, San Diego, CA) and were cultured with LC2029 strain (Manifoldness 
of Infection (MOI) was 200 bacteria/cell), or in the presence of Slp2 (100 µg/ml), or MaLP-2 
(50 nM) as a positive control. Supernatants were removed at the end of the treatment period, 
and the cells were lysed with GloLysis buffer. The luciferase activity was determined using 
the Bright-Glo Luciferase Assay System according to the manufacturer
’
s protocol (Promega, 
Madison, WI). Luminescence was measured using a Victor 2 1420 multilabel microplate 
counter with Wallac 2.01 software (Perkin Elmer Life Sciences, Boston, MA). 
 
In vitro adhesion assay for lactobacilli 
The lactobacilli adhesion to immature Caco-2 cells (in vitro biomodelling of small intestinal 
enterocyte immaturity in preterm infants) and adhesion to immature HT-29 cells (in vitro 
biomodelling of large intestinal colonocytes immaturity in preterm infants) were performed 
as described in [18] in modification. Briefly, suspensions of lactobacilli in antibiotic-free 
medium at 2x10
8
 CFU/ml were added to monolayers of immature Caco-2 cells with a layer 
of 80-100% at MOI 200:1 bacterial cell/epithelial cell ratio. Suspensions of lactobacilli were 
added to monolayers of immature HT-29 cells at the same conditions. Co-cultures were 
incubated for 2 h at 37°C in 5% CO2 atmosphere. After 2 h, co-cultures were washed three 













eosin (Pan Eco, Russia) and examined under the Leica DM 4500B microscope (Leica, 
Canada). Adherent bacteria quantified by using the Leica IM modular applications system 
(Leica, Canada). Adhesion of lactobacilli cells to epithelial cells was expressed as a 
percentage of 100 randomly selected epithelial cells with adhering bacteria and as average 
number of adhering bacteria per epithelial cell. 
 
In vitro adhesion assay for bifidobacteria 
The studies of bifidobacteria BLI-2780 strain adhesion to fully differentiated Caco-2 cells 
and HT-29 cells were performed as described in [36] with some modifications. Briefly, 
Caco-2 and HT-29 cells were seeded in 24-well plates. Adhesion experiment were performed 
15d after confluence. The viable cells number, counted in a Neubauer chamber, was about 
5×10
5 
cells per well. The 48 h-old BLI-2780 culture was collected by centrifugation, washed 





the reference material (100% values), 1 ml of the original bacteria used in the adhesion assay 
was centrifuged, the cells were re-suspended in 200 µl trypsin/EDTA plus 200 µl PBS, 
frozen and stored at -20°C until quantification of the bacteria. BLI-2780 suspension 1×10
8 
cells were incubated with a monolayer of fully differentiated Caco-2 or HT-29 cells at 37°C, 
5% CO2 for 2 h. After 2 h of incubation, cell monolayer was washed three times with PBS, to 
remove unbound bacteria, detached from plastic surface by incubation with 200 µl 
trypsin/EDTA per well (10 min, 37°C). Cell suspension was incubated in lysis buffer (20 
mM Tris-HCL, 2 mM sodium EDTA, 1.2% Triton X-100, 20 mg/ml lysozyme). 
Quantification of the adherent bacteria was performed by quantitative PCR targeting the 16S 
rRNA gene. The primer sequences used in adhesion assay: Bif F (5’-
TCGCGTCTGGTGTGAAAG-3
’ 





Estimates of the number of genome copies in the standard were based on the genome size 2.6 
Mb. PCR was performed in a 7500 Fast Real-Time PCR System (Applied Biosystems, CA) 
using SYBR Green fluorophore. Amplification was carried out in 20 µl containing 1 µl of 
each primer, 10 µl SYBR Green PCR Master Mix and 2 µl of bacterial DNA. PCR was 
conducted at 95°C for 10 min, followed by 40 cycles consisting of 20 s at 95°C, 20 s at 56°C, 
30 s at 60°C. Adhesion level was expressed as the number of adherent bacteria divided by 















The concentration of cytokines IL-8, IL-6 in supernatants from Caco-2 cells cultured was 
measured with ELISA kits (Biosource International, Carlsbad, CA), TNFα, IL-1β was 
measured with ELISA kits (State Research Institute of Highly Pure Biopreparations, St-
Petersburg, Russia), RANTES was determined with ELISA kit (Invitrogen) and CXCL1 was 
determined with Platinum ELISA (Affymetrix, Santa Clara, CA, USA), following protocols 
provided by the manufacturer. 
 
Co-aggregation assay 
The ability of Lactobacillus strains to co-aggregate with foodborne pathogen strains (Table 
1) was tested according to [25] with some modifications. Briefly, bacteria were grown for 24 
h at 37°C and cells harvested by centrifugation at 5000 g for 15 min, washed twice and 
resuspended in acetate buffer (pH 4.0) to give viable counts of approximately 2×10
9 
CFU/ml. 
To analyze co-aggregative abilities, equal volumes of each Lactobacillus strain 2×10
9 
CFU/ml were mixed with 2×10
9 
CFU/ml C. jejuni, S. enteritidis or E. coli by vortexing for 
10 s. Control test tubes containing individual bacterial samples were set up at the same time. 
Test tubes left at room temperature with no agitation were observed every thirty minutes for 
a total of three hours,  analyzed visually and ranked based on a degree of co-aggregation: 0 
for no visible co-aggregates in the cell suspension; + for small uniform co-aggregates in the 
suspension, with small clusters or sand-like grains of cells seen with careful observation, 
generally with minimal pellet; ++ for aggregates that are easily seen but may not settle 
immediately, clusters form and are distinct from supernatant or remaining suspension, but do 
not settle and/or do so very slowly; +++ for larger aggregates which settle and leave some 
turbidity in the supernatant fluid, with aggregates forming pellets at the bottom of the tubes, 
but some bacteria remaining in suspension; ++++ for larger aggregates, which settle 
immediately and leave clear supernatant fluid, often strong aggregation leaves clear 
supernatant easily visible between very large clusters in suspension. 
 
Protection of immature Caco-2 and HT-29 cell monolayers against foodborne pathogens by 
Slp2 and LC2029 strain  
Caco-2 and HT-29 cells were seeded into 6-well plates and grown to 100% monolayers. Cell 
culture medium was replaced with antibiotic-free medium. Plates with monolayers were 















CFU/ml) was added to the wells of second group. The plates were co-incubated 
for 1 h under 5% CO2 at 37°C. Each group of plates was divided into 3 subgroups. 
Campylobacter cell suspension (10
6 
CFU/ml) was added to the wells of subgroup 1, 
Salmonella cell suspension (10
6 
CFU/ml) was added to the wells of subgroup 2, E. coli cell 
suspension (10
6 
CFU/ml) was added to the wells of subgroup 3. The plates were co-incubated 
for 1 h under 5% CO2 at 37°
 
C. Caco-2 and HT-29 cell monolayers were washed three times 
with PBS to remove unbound bacteria and Slp2. Then gentamicin (50µg/ml) was added to 
each well and the monolayers were further incubated for 24 h. Caco-2 and HT-29 cell lysates 
were prepared for the assessment of caspase-9 and caspase-3 activities. 
 
Caspase-3 and caspase-9 activities assessment  
Сaspase-3 and caspase-9 activities (as markers of epithelial cell apoptosis) were studied 
using the Caspase Activity Kit (Sigma-Aldrich, USA) according to the manufacturer’s 
protocol. Caco-2 cell lysates were prepared by incubating cells in extraction buffer or 15 min 
on ice. After centrifugation (20,000g, 15 min, 4°C ), the supernatants were harvested and 
incubated with the substrate Ac-DEVD-ρNA (caspase-3) or AC-LEND-ρNA (caspase-9) in a 
96-well micro plate for 2h at 37°C. The absorbance values of the yellow formazan were 
determined at 405 nm by a micro plate reader (Thermo Scientific Multiscan, MA., USA).The 
caspase activity was expressed as the relative enzyme activity to the control group. 
 
Adhesion of C. jejuni, S. enteritidis and E. coli to the monolayers of Caco-2 or HT-29 cells 
protected by Slp2 or LC2029  
For the adhesion assay, plates with Caco-2 or HT-29 monolayers with antibiotic-free medium 
were divided into two groups. Slp2 (100 µg/ml) was added to the wells of first group, 
LC2029 strain (10
9 
CFU/ml) was added to the wells of second group, whilst sterile PBS was 
added in the control groups. The plates were incubated for 1 h at 37°C in 5% CO2. Each 
group of plates was divided into 3 subgroups. Campylobacter cell suspension (10
6 
CFU/ml) 
was added to the wells of subgroup 1, Salmonella cell suspension (10
6 
CFU/ml) was added to 
the wells of subgroup 2, E. coli cell suspension (10
6 
CFU/ml) was added to the wells of 
subgroup 3. The plates were incubated for 1 h at 37°C under 5% CO2. Caco-2 and HT-29 cell 
monolayers were washed three times with sterile PBS to remove unbound bacteria and Slp2, 
fixed with methanol, stained with azure-eosin (Pan Eco, Russia) and examined under the 













Leica IM modular applications system (Leica, Canada). Adhesion of bacterial cells to 
epithelial cells was expressed as average number of adhered bacteria per epithelial Caco-2 or 
HT-29 cell. 
 
Antagonistic activity assay 
Antagonistic activity of LC2029 strain to foodborne pathogens was studied by agar spot test 
according to Schillinger and Lucke [37] in modifications. Briefly, suspension of lactobacilli 
(3 µl 5×10
9 
CFU/ml) were spotted on the surface of MRS 1.2% agar and incubated 
anaerobically for 24 h at 30°C to form colonies. To assess the antibacterial activity of Slp2, 
wells were made in the gel of MRS 1.2% agar, 100 µg of Slp2 was added to them and plates 
were incubated for 24 h at 4°C. Then 100 µl of an overnight culture of the indicator bacteria 
(approximately 10
8 
cells) was mixed with 7 ml of soft brain-heart infusion (BHI) or Luria-
Bertrani medium (LB) agar and poured over the plate. The plates were incubated at 37°C 24-
48 h and were examined for the presence of the inhibition zones. A clear zone of more than 1 
mm around a spot was scored as positive. 
 
Quantitative H2O2 determination assay 
H2O2 production by lactobacilli was tested colorimetrically through detection of the color 
development by o-dianizidine in the presence of horseradish peroxidase (Sigma, USA) as 
described in [38]. Absorbance reading (A405 nm) was measured. Content of peroxide was 
quantified by comparing the values obtained with those of an H2O2 standard curve. 
 
Statistical analysis 
The results were analyzed using a one-way ANOVA and represented means ± standard errors 
of the means (SEM). Statistically significant differences were accepted at p<0.05. 
 
Results and discussion 
L. crispatus LC2029 strain produces Slp 
According to the light microscopy (Fig. 1A), the cells of vaginal LC2029 strain are straight 
or curved rods that do not form abundant auto-aggregates. This property distinguishes the 
LC2029 strain from other Slp-positive lactobacilli strains L. crispatus  JCM5810, L. 
crispatus  Zj001, and L. acidophilus M920 with the auto aggregation ability [24,25,39]. TEM 













layer is the plasma membrane, (ii) the middle layer - cell wall consist of peptidoglycan, and 
the third outermost layer represents the S-layer, one part of which is located on the cell wall, 
and the second part can diffuse into the culture medium (Fig. 1C). The genome of LC2029 
strain contains genes encoding Slp1 and Slp2 [40]. The predicted molecular masses of the 
mature Slp1 and Slp2 proteins are is 61.16 kDa and 45.98 kDa respectively. The Slp fraction 
of LC2029 strain analyzed using SDS-PAGE and Western blotting analysis revealed no 
presence of Slp1 under the growth conditions we used. In contrast, the Slp2 protein was 
found to be highly expressed, with the expected size of 46.0 kDa (Fig. 1D). L. crispatus  
ZJ001 also has two S-layers genes slpa and slpb with only slpa gene being expressed at the 
conditions tested [41]. 
 
Sequence analysis of Slp2 protein 
Slps in other bacteria are known have a variety of functions, some of which are essential for 
bacterial physiology and survival in specific environments [42]. The human vaginal LC2029 
strain is highly adhesive to cervicovaginal epithelial cells due to the presence of Slp2 on its 
surface [18]. Alignment of the primary structures of Slp2 (slp2-2029) of vaginal L. crispatus  
LC2029, SlpA (slpa-ZJ001) of L. crispatus  ZJ001 isolated from pig intestines [41], and 
CbsA (cbsa-5810) of L. crispatus  JCM 5810 isolated from chicken intestines [43] is shown 
in Fig. 2. The amino acid sequence identity between SlpA and CbsA was as high as 84%, 
whilst the identity levels of these sequences with that of Slp2 were only 49% and 50% 
(respectively). The C-terminal regions of the three proteins appear to be more conserved than 
the N-terminal regions (Fig. 2), which is similar to Slps L. helveticus and L. acidophilus 
[39,44], but different from Slps of L. brevis  with N-terminal regions being more conserved 
[45]. N-terminal regions of Slps are responsible for binding of bacteria to epithelial cells or 
pericellular tissue components in specific niches. Variation in amino acid sequences in the N-
terminal regions of the Slps may contribute to unique biological properties of lactobacilli 
[42]. The Slp of L. acidophilus M92 was proposed to mediate binding to porcine ileal 
epithelial cells since removal of the Slp by LiCl resulted in significant reduction of adhesion 
of this strain to intestinal epithelium [39]. L. helveticus M92 and its Slps were proved to be 
involved in competitive exclusion with S. enterica serovar Typhimurium FP1 in mice 
intestine [46]. Extracellular matrix of human cervicovaginal, urethral and intestinal epithelial 
cells contains type IV collagen [47,48]. The CbsA-expressing strain L. crispatus JCM5810 













and, with a lower affinity, to type V collagen and fibronectin. Slp2-expressing strain LC2029 
is able to type IV collagen with high affinity [18] and SlpA-expressing strain L. crispatus 
Zj001 adhered efficiently to human cervical HeLa cells containing type IV collagen in 
extracellular matrix [24]. Thus, a common property of compared Slps produced by L. 
crispatus strains was their ability to interact with extracellular matrix components: type I and 
type IV collagens, laminin and fibronectin. L. acidophilus is one of the major species of this 
genus found in human and animal intestines. Slp-expressing strain L. acidophilus JCM 1132 
did not exhibit detectable adhesiveness to collagens, laminin and fibronectin [49]. 
 
Effect of Slp2 on survival of LC2029 strain in simulated gastric and intestinal stresses 
The viability of lactobacilli strains during transit through the GIT of the host is very 
important for the manifestation of their probiotic properties. LC2029 strain was found to be 
resistant to both acidic conditions and bile (Table 2). Removal of Slp2 reduced survival of 
the LC2029 cells in simulated gastric and intestinal juices by 2-3 logs. A similar pattern was 
observed for L. crispatus  ZJ001 containing SlpA on its surface [24]. A vaginal L. crispatus 
strain LC1385 not expressing Slps was very sensitive to gastric and intestinal stresses (Table 
2). These results confirmed the protective role of Slp2 for the survival of LC2029 strain in 
the gastric and intestinal environments. Slp2 appears to be able to assist in the transition of 
vaginal LC2029 cells of the mother into a new intestinal microecological niche of the infant 
for the implementation of new biological functions protecting newborns from colonization 
with foodborne pathogens. 
 
Slp2 mediates adhesion of LC2029 lactobacilli and BLI-2780 bifidobacteria strains to Caco-
2 and HT-29 cells 
One of the important properties of probiotic lactobacilli and bifidobacteria is their ability to 
adhere to the target sites with epithelial cells and mucosal surfaces leading to formation of a 
barrier preventing colonization by pathogens. Monolayers of immature Caco-2 cells were 
used for modelling adhesive properties of immature small intestine enterocytes in extremely 
low-gestational-age newborns. Adhesion of vaginal LC2029 and LC1385 strains to immature 
intestinal Caco-2 cells was evaluated by a light microscopy (Fig. 3). It could be visually 
observed that in contrast to Slp-negative LC1385 strain with reduced properties to adhesion, 
bacterial cells of LC2029 strain expressing Slp2 on their surface tightly cover the immature 













Caco-2 cells and immature HT-29 cells significantly decreased, when Slp2 was removed 
from the bacterial cells by LiCl (Table 3). Premature birth results in a delayed and reduced 
level of gut colonization by Bifidobacterium species [50]. This abnormal pattern is thought to 
affect intestinal development and contribute to a higher risk of foodborne infectious diseases 
especially NEC. It was shown that birth gestational age acts as a major determinant of 
bifidobacterial colonization in the premature infant, suggesting the role of gut maturation 
[50]. The ability of bifidobacteria to bind and interact with the intestinal epithelium plays an 
important role in gut colonization and modulation of host immune system. B. infantis ATCC 
15697 grown on human milk oligosaccharides (HMO) had a significantly higher rate of 
adhesion to both fully differentiated Caco-2 and HT-29 cells [36]. We used fully 
differentiated Caco-2 and HT-29 cells for in vitro biomodelling of Slp2 participation in 
bifidobacteria-intestinal epithelial cells interactions. Soluble Slp2 enhanced the adhesion of 
bifidobacteria BLI-2780 strain to Caco-2 and HT-29 cells (Fig. 4). The main microecological 
niche for bifidobacteria is the large intestine. Slp2- treated HT-29 cells absorbed BLI-2780 
bacteria more intensively on their surface compared to Caco-2 cells (p<0.05). The Slp2 was 
the key factor of LC2029 strain for adhesion to cervicovaginal mucosal surface [18]. To 
summarize, these results suggest that Slp2 is playing a role in adhesion of LC2029 cells to 
host cells and can increase the ability of the small intestinal Caco-2 cells and large intestinal 
HT-29 cells for interaction with bifidobacteria BLI-2780 strain. 
 
Slp2 and LC2029 strain do not have cytotoxic and pro-inflammatory effects on Caco-2 and 
HT-29 cells  
Slp2 and LC2029 strain do not affect Caco-2 cell and HT-29 cell viability (Fig. 5A, C). At 
the same time they promoted NF-kB driven luciferase activity in Caco-2 and HT-29 cells 
similar to that induced by the toll-like receptors (TLR) 2/6 ligand MALP-2 (Fig. 5 B, D) at 
significantly higher levels than the medium control (p<0.01). However, only MALP-2 in 
contrast to Slp2 and LC2029 strain, induced a significant IL-8 up-regulation in Caco-2 cells 
(Fig. 6A). Slp2 and LC2029 strain reduced IL-8 production induced by the TLR2/6 ligand 
MALP-2 in Caco-2 cells (Fig. 6A). These data suggest that Slp2 and CL2029 strain are 
recognized by epithelial cells as TLR2/6 ligands. Recognition of LC2029 strain and its 
isolated surface structure Slp2 by TLRs is required for intestinal homeostasis. It is known 
that IL-8 is a powerful chemo attractant and activator of neutrophils [51]. IL-8 has also been 













and mucosal destruction [52]. Our data suggest that LC2029 strain and Slp2 tune in the host 
innate immune response to avoid production of pro-inflammatory cytokines in the presence 
of a potent NF-kB activation. MALP-2 induced significant increase in the level of IL-1β 
(p<0.01) and of TNFα (p<0.001) in Caco-2 cells, while LC2029 strain and Slp2 had no effect 
(Fig. 6 C, D). At the same time, level of IL-6 in LC2029 strain colonized Caco-2 cells or in 
the presence of Slp2 was increased (Fig. 6B). IL-6 is an anti-inflammatory cytokine, a repair 
and cytoprotective factor [53]. It plays direct role in the protection of various cell types, such 
as hepatocytes [54], renal [55] and lung epithelia [56] from injury. IL-6 reduces the level of 
apoptosis among Ag-stimulated cells [57]. It is crucial for the protection of endothelial cells 
against H2O2 – induced cell death [58]. LC2029 strain produces high level H2O2 [18], and IL-
6 is needed to support homeostatic balance in intestinal tract of newborns. Thus, LC2029 
strain together with its Slp2 induce NF-kb activation and at the same time maintain low 
levels of inflammation-associated cytokines, which is important for the microorganism
’
s 
potential use as a vaginal probiotic transmitted by mother to child during birth to form a 
healthy intestinal microbiota that control the pathogenic bacteria. NF-kB is a major 
transcription factor that plays a key role in inflammatory diseases. The net effect of NF-kB 
activation depends on the cell and tissue properties, the interaction of intra- and extra-cellular 
factors, and the nature of the activating signal [59]. Vaginal Lactobacillus species (L. 
crispatus , L. jensenii and L. acidophilus) can cause NF-kB activation and yet maintain low 
levels of IL-8 and RANTES [35,60]. Vaginal L. jensenii can suppress IL-8 induced by TLR 
ligands [61].  
 
Slp2 inhibits levels of NEC pro-inflammatory mediators CXCL1 and RANTES produced by 
immature Caco-2 cells during their functional differentiation and maturation 
Epithelium of the small intestine of preterm infants is immature unlike full-term infants [50]. 
Recently, Hayashi and colleagues reported that immature Caco-2 cells secrete CXCL1 and 
RANTES during their maturation and differentiation [62]. Relevant studies using a mouse 
model suggested a link between higher incidence of NEC and elevated intestinal expression 
of CXCL1 mRNA [63]. RANTES is also an effective activator of leukocytes, which play a 
key role in a wide range of inflammatory disorders, including NEC [64]. We used immature 
Caco-2 cells as a relevant in vitro bio-model to assess the ability of Slp2 to inhibit chemokine 
CXCL1 and RANTES production in immature small intestine enterocytes during their 













process of Caco-2 cell differentiation within 15 days is accompanied by an increase in the 
production of CXCL1 and RANTES (Fig. 7). Slp2 inhibited production of CXCL1 (Fig. 7A) 
and RANTES (Fig. 7 B). The results indicate feasibility for using Slp2 for the NEC 
prevention in prematurely born infants at a time when enteral nutrition is contraindicated. 
 
Slp2 and LC2029 strain inhibited foodborne pathogen-induced activation of caspase 9 and 
caspase 3 in Caco-2 and HT-29 cells 
Foodborne pathogens C. jejuni, S. enteritidis, and E. coli can adhere to enterocytes, activate 
caspase 9 and caspase 3 and induce apoptosis through a mitochondria-mediated pathway in 
HT-29 cells [31] and Caco-2 cells [65]. Slps isolated from L. acidophilus NCFM [31] and L. 
acidophilus ATCC 4356 [65] strains decreased pathogen-induced Сaspase-3 and caspase-9 
activation leading to inhibition of apoptosis of HT-29 cells [31] and Caco-2 cells [65]. In our 
experiments the model foodborne pathogens C. jejuni, S. enteritidis and E. coli at 
concentration 10
6
 CFU/ml activated caspase 9 and caspase 3 in Caco-2 cells (Fig. 8A, B) and 
in HT-29 cells (Fig. 9A, B). Pre-treatment of Caco-2 and HT-29 cells with Slp2 at 
concentration 100 µg/ml or LC2029 strain at concentration 10
9 
CFU/ml prior to introducing 
C. jejuni, S. enteritidis or E. coli into the culture medium, inhibited pathogen-induced 
activation of caspase 9 and caspase 3 (Fig. 8A, B and Fig. 9A, B). This effect was due to the 
ability of the Slp2 and LC2029 strain to inhibit the adhesion of foodborne pathogens to Caco-
2 and HT-29 cells (Table 4). The excess of Slp2 or bacterial LC2029 cells added to the 
culture medium before introducing pathogens was partially spent on interaction with Caco-2 
cell and HT-29 cell monolayers, which is necessary to protect them from foodborne 
pathogens (C. jejuni, S. enteritidis or E. coli ). The remainder of the Slp2 or LC2029 cells 
took part the formation of aggregates and co-aggregates with foodborne pathogens. In the 
process of washing of the Caco-2 and HT-29 monolayers, the aggregates and co-aggregates 
of the foodborne pathogens were removed from the cultural wells. The results of our studies 
indicate that the Slp2 and LC2029 strain protect epithelial cell monolayers from direct 
interactions with foodborne pathogens, which induce caspase 9 and caspase 3 activation in 
the intestinal epithelial cells and apoptosis development. 
 
Bacterial cells of LC2029 strain surrounded by Slp2 co-aggregate with gut pathogens 
Vaginal lactobacilli co-aggregation abilities may form a barrier that prevents colonization of 
women
’













aggregation capacities of vaginal Slp-positive LC2029 strain and Slp-negative LC1385 strain 
with model Proteobacteria related to foodborne pathogens (C. jejuni, S. enteritidis and E. 
coli). Two different vaginal L. crispatus strains Slp-positive LC2029 strain and Slp-negative 
LC1385 strain were found to have differing co-aggregative abilities (Table 5). LC2029 is 
strong co-aggregator of C. jejuni, S. enteritidis and E. coli. The Slp2 was responsible for the 
ability of LC2029 strain to co-aggregate foodborne pathogens. After treating of LC2029 cells 
with LiCl, their ability to co-aggregate with foodborne pathogens was lost. It was shown in 
vitro by Wooten that CbsA producing L. crispatus JCM5810 of chicken origin is a strong co-
aggregator of C. jejuni [25]. Strain JCM5810 also effectively reduced C. jejuni colonization 
in chicken intestine. C. jejuni growth in co-culture with JCM5810 cells was inhibited after 6 
h and was eliminated after 16 h [68]. Thus, the co-aggregation ability of LC2029 strain may 
contribute to prevention of colonization of human intestinal mucosal surface by foodborne 
pathogens. 
 
Antagonistic activity of LC2029 strain and Slp2 against foodborne pathogens 
As shown in Table 6. Slp2 alone did not inhibit the growth of intestinal pathogens C.jejuni, 
S. enteritidis and E. coli. Slp2-positive LS2029 strain and Slp2-negative LS2029 strain (after 
shedding of Slp2 from the surface of the lactobacilli cells in the presence of LiCl) were able 
to inhibit growth of these pathogens more effectively than Slp-negative LC1385 strain (p< 
0.05). It has been shown earlier [18] that Slp-positive LC2029 strain, in contrast to Slp-
negative LC1385 strain, is an effective producer of H2O2. Shedding of Slp from the surface 
of the lactobacilli cells in the presence LiCl do not decrease their viability [69] and effective 
production of H2O2 by Slp2-negative LC2029 strain (Table 7). The formation of co-
aggregates by Slp-positive LC2029 strain with C. jejuni, S. enteritidis and E. coli (Table 5) 
creates favorable conditions under which the LC2029 strain uses H2O2 as a short-term 
bactericidal weapon against intestinal pathogens. In 90% of cases premature births are the 
results or urogenital infections due to decreased level of vaginal lactobacilli or their complete 
disappearance leading to the development of systemic inflammation [70]. In the process of 
childbirth, such a mother cannot naturally transmit beneficial lactobacilli bacteria similar to 
LC2029 to the baby. As a result, such a child may develop disbiosis, characterized by 
increased amounts of Proteobacteria in intestinal microbiota leading to intestinal 
inflammation and NEC development [27]. NEC is normally induced by non-pathogenic E. 













of lactobacilli and bifidobacteria [27]. The results of our studies indicate a possibility of 
using LC2029 strain as a probiotic for prevention of NEC in preterm infants. 
 
Conclusions  
In this study, we revealed new functions of Slp2 and Slp2-positive vaginal LC2029 strain. 
Slp2 provides tolerance of the LC2029 strain to gastric and intestinal stresses that makes it 
possible to relocate the strain from the vaginal microecological niche of mother to the child 
intestinal microecological niche. Slp2 allows the LC2029 strain to colonize the human 
intestine, assisting in antagonistic activity against foodborne pathogens and preventing 
apoptotic markers caspase 9 and caspase 3 activation induced by these pathogens in Caco-2 
and HT-29 cells. Slp2 was found to possess anti-adhesive activity reducing binding of 
pathogenic bacteria to the host cells. This is a first study providing the evidences that Slp2 
inhibits CXCL-1 and RANTES production by immature Caco-2 cells during their maturation 
and differentiation, inhibits IL-8 production in Caco-2 and HT-29 cells induced by MALP-2 
agonist of TLR2/6 receptors. Treated by Slp2 Caco-2 and HT-29 cells increase their ability to 
interact with bifidobacteria. These data indicate feasibility of using Slp2 and LC2029 strain 
for prevention of NEC development in very low birth weight premature infants. The results 
also indicate the need to continue research using relevant in vivo bio-models for elucidation 
of the roles of Slp2 and LC2029 strain in the formation of intestinal microbiota, leading to 
prevention of growth of intestinal Proteobacteria and NEC development in preterm infants 
and to increase in the resistance to foodborne pathogens in children and adults. 
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Figure 1. Detection of S-layer on the surface of LC2029 strain. 
(A) Light microscopy of L. crispatus LC2029 cells after methylene blue staining. (B, C) 
Transmission electron microscopic image showing: (B) S-layer located on the bacterial 
surface, (C) S-layer non-covalently bound to a cell wall can desquamate from its surface and 
enter the culture medium. CM, cytoplasmic membrane; CW, cell wall; S, S-layer. (D) 
Western blotting of extracted and purified Slp2 from bacterial surface. Lane 1. Slp2. Sizes of 
the molecular mass marker proteins are indicated on the left. 
 
Figure 2. Alignment of the primary structures of Slps from L. crispatus LC2029 (2029-slp2), 
from L. crispatus ZJ001 (ZJ001-slpa), and from L. crispatus JCM 5810 (5810-cbsa). 
Sequences of three Slps of L. crispatus strains were aligned with the Clustal Omega program 
(https://www.ebi.ac.uk/Tools/msa/clustalo/).  
"*" - means that the residues are identical in all sequences in the alignment. 
":" - means that conserved substitutions are observed. 
"." - means that semi-conserved substitutions have been observed. 
 
Figure 3. Adhesion of the LC2029 and LC1385 lactobacilli strains to monolayers of 
immature Caco-2 cells. 
(A) – intact immature Caco-2 cells (control), (B) - adhesion of bacterial cells L. crispatus 
LC2029 strain containing Slp2 on their surface, (C) - adhesion of bacterial cells L. crispatus 
LC1385 Slp-negative strain. Light microscopy after azure-eosin staining. Monolayers of 
immature Caco-2 cells were used. 
 
Figure 4. Effect of Slp2 on the adhesion of B.infantis BLI-2780 strain to fully differentiated 
Caco-2 and HT-29 cells. 
(A) Adhesion of B. infantis BLI-2780 to fully differentiated Cao-2 cells. (B) Adhesion of B. 
infantis BLI-2780 to fully differentiated HT-29 cells. 
Fully differentiated Caco-2 cells or HT-29 cells were treated by Slp2 for 30 min at 37°C in 
anaerobic condition, then cell monolayers were washed three times with sterile PBS, to 
remove unbound Slp2. Bifidobacteria 2×10
8
 cells/ml were incubated with Caco-2 cells or 
HT-29 cells for 2 h at 37°C in anaerobic conditions, then were washed three times with 













on 16S rRNA encoding gene. The results are presented as the percentage of bacteria 
recovered vs. total applied to monolayers. Values are means and SEM. All data were 
representative of six independent experiments, tested in triplicate. *p<0.05 - adhesion of B. 
infantis BLI-2780 to epithelial cells at concentration of Slp2 in medium 25-50 µg/ml vs. 0: 
**p<0.01 at concentration of Slp2 in medium 75-100 µg/ml vs. 0. 
 
Figure 5. Effect of Slp2 and LC2029 strain on the Caco-2 and HT-29 cell viability and NF-
kB activity.  
(A) Viability of Caco-2 cells and (C) HT-29 cells assessed at 24 h postcolonization with 
LC2029 strain. (MOI was 200 bacteria/cell) or in the presence of Slp2 (100 µg/ml). (B) 
Induction of NF-kB expression in Caco-2 cells and (D) in HT-29 cells. 24-h lysates from 
Caco-2 cells or HT-29 cells cultured with LC2029, Slp2 or MaLP-2 (50 nM) as a positive 
control. Luciferase activity measured in lysates from cultu es. Bars are means and SEM. All 
data were representative of six independent experiments, tested in triplicate. ***p<0.001 
Slp2, LC2029 and MALP-2 vs. medium control. 
 
Figure 6. Level of cytokines IL-8, IL-6, TNFα and IL-1β secreted by immature Caco-2 cells 
in the presence of Slp2 or LC2029. 
IL-8 and Il-6 levels determined in supernatants cultured for 24 h, TNFα and IL-1β levels 
determined in supernatants cultured for 8 h in the presence of Slp2 (50 µg/ml), LC2029 or 
MALP-2 as a positive control. Bars are means and SEM. All data were representative of six 
independent experiments, tested in triplicate. (A) **p<0.01 medium, Slp2 or LC2949 vs. 
MALP-2; *p<0.05 MALP-2 vs. MALP-2+Slp2 or MALP-2+LC2029. (B) *p<0.05 Slp2 or 
LC2029 vs. medium; **p<0.01 MALP-2 vs. medium; (C) ***p<0.001 MALP-2 vs. medium, 
Slp2 and LC2029; (D) **p<0.01 MALP vs. medium, Slp2 or LC2029. 
 
Figure 7. Slp2 from LC2029 strain inhibits CXCL1 and RANTES secretion by Caco-2 cells 
during their 15-days functional differentiation.  
(A) CXCL1 and (B) RANTES in supernatants from Caco-2 cells determined by ELISA.  
Grey bars – supernatant from Caco-2 cells in DMEM; white bars – supernatant from Caco-2 
cells in DMEM+Slp2 (100 µg/ml). Bars are means and SEM. All data were representative of 
six independent experiments, tested in triplicate. *p<0.05 supernatant from Caco-2 cells in 













DMEM (15 days) vs. DMEM+Slp2 (15 days); #p<0.001 supernatants from Caco-2 cells in 
DMEM (15 days) vs. Control (fresh DMEM). 
 
Figure 8. Effects of Slp2 and LC2029 strain on the caspase activity in foodborne pathogens-
infected Caco-2 cells.  
(A) Caspase-9 activity in Caco-2 cells. (B) Caspase-3 activity in Caco-2 cells. Bars are 
means and SEM. All data were representative of six independent experiments, tested in 
triplicate. **p<0.01 vs. medium control; ##p < 0.01 Slp2+Camp and LC2029 +Camp vs. 
Camp alone; Slp2+Sal and LC2029+Sal vs. Sal alone; Slp2+E. coli and LC2029+E. coli vs. 
E. coli alone. 
 
Figure 9. Effects of Slp2 and LC2029 strain on the caspase activity in foodborne pathogens-
infected HT-29 cells. 
(A) Caspase-9 activity in HT-29 cells. (B) Caspase-3 activity in HT-29 cells. Bars are means 
and SEM. All data were representative of six independent experiments, tested in triplicate. 
**p<0.01 vs. Medium control; ##p<0.01 Slp2+Camp and LC2029+Camp vs. Camp alone; 
















Table 1. Microorganisms used in this study 
Microorganism Strain Growth conditions Comments 
Lactobacillus crispatus LC 2029 MRS*37°C in 5% CO2 or 
anaerobically 48 h 
IBPM RAS
a
. Vaginal strain 
was originally isolated in 
healthy woman. 
Lactobacillus crispatus LC 1385 The same IIEb. Vaginal clinical isolate 




BLI-2780 MRS 37°C anaerobically 48 h IIE. Intestinal strain was 
originally isolated in healthy 
infant at 14 day of age. 
Campylobacter jejuni 33291 BHI** 42°C in 
microaerophilic conditions 
LB*** 18 h at 37°C 
ATCC
c 
Salmonella Enteritidis 25928 The same ATCC 
Escherichia coli 0157:H7 43889 The same ATCC 
 
a
 Russian Collection of Microorganisms at the Skryabin Institute of Biochemistry and Physiology of 
Microorganisms, Federal Research Center “Pushchino Scientific Center for Biological Research, RAS” 
Pushchino, Moscow Region, Russia. 
b
 Collection of Microorganisms at the Institute of Immunological Engineering (IIE). Department of 
Biochemistry of Immunity and Biodefence, Lyubuchany, Moscow Region, Russia. 
c
 American Type Culture Collection, Manassas, VA, USA. 
* Man-Rogosa-Sharpe (MRS) broth or agar containing plates. (Himedia, India). 
** Brain-Heart Infusion (BHI) broth supplemented with 0.5% yeast extract or agar containing BHI plates. 
(Sigma-Aldrich, St. Louis, MO, USA). 















Table 2. Tolerance of vaginal LC2029 strain containing Slp2 on its surface to gastric and intestinal stresses. 
Strain Gastric stress Intestinal stress 
10 min 30 min 60 min 5 hours 
CFU/ml CFU/ml CFU/ml CFU/ml 
Experiment Control Experiment Control Experiment Control Experiment Control 




 1.75 x 10
7
 2.18 x 10
7
 1.05 x 10
7
 2.20 x 10
7
 1.75 x 10
6
 2.43 x 10
7
 
LC2029* 1.56 x 10
5
 1.14 x 10
7
 1.62 x 10
5
 1.17 x 10
7
 1.15 x 10
4
 1.63 x 10
7
 1.20 x 10
4
 2.25 x 10
7
 
LC1385** 0.86 x 10
5
 4.26 x 10
7
 0.67 x 10
5
 4.31 x 10
7
 0.53 x 10
4
 4.25 x 10
7
 3.75 x 10
4
 4.16 x 10
7
 
Controls – strains cultured in the absence of gastric and intestinal stresses. Values represent means and 
SEM. All data were representative of six independent experiments, tested in triplicate. 
* 
LC2029 strain after 
removal of the Slp2 from the cell surface by LiCl; 
**




Table 3. Effect of Slp2 on the adhesion of LC2029 strain to immature Caco-2 cells and immature HT-29 
cells. 
Epithelial cells Strain of lactobacilli % cells with adhering 
lactobacilli 
No. of adhering bacteria/cell 
Caco-2 LC 2029 100*** 51.7 ± 8.6*** 
LC 2029 (LiCl treatment) 7.3 ± 3.4 4.6 ± 1.3 
LC 1385 6.5 ± 2.7 3.5 ± 0.7 
HT-29 LC 2029 100*** 39.4 ± 6.2*** 
LC 2029 (LiCl treatment) 5.8 ± 1.7 3.5 ± 1.3 
LC 1385 4.9 ± 2.6 2.8 ± 0.9 
Monolayers of immature Caco-2 and HT-29 cells were used with a layer of 80%. Values represent means 
and SEM. The adhesion experiment was performed six times, tested in triplicate. 
***
p<0.001 differences 















Table 4. Slp2 and LC2029 strain reduce of foodborne pathogens adhesion to Caco-2 cells and HT-29 cells. 
Intestinal epithelial cells Adherent bacteria per epithelial cell 
Campylobacter jejuni ATCC 
33291 
Salmonella enteritidis ATCC 
25928 
Escherichia coli 0157:H7 
ATCC 43889 
Caco-2 38.4 ± 2.35 21.9 ± 3.64 26.5 ± 4.27 
Caco-2 + Slp 2 0.9 ± 0.11* 0.8 ± 0.12
#
 0.6 ± 0.05
χ
 
Caco-2 + LC2029 0.6 ± 0.08* 0.7 ± 0.05
#
 0.8 ± 0.07
 χ
 
HT-29  24.1 ± 2.75 32.6 ± 2.83 27.8 ± 3.52 
HT-29 + Slp 2 0.5 ± 0.06* 1.1 ± 0.09
#
 0.9 ± 0.08
χ
 
HT-29 + LC2029 0.7 ± 0.05* 0.8 ± 0.06
#




p<0.001 adhesion of C. jejuni to Caco-2 or HT-29 cells vs. adhesion of C. jejuni to Caco-2+ Slp2; Caco-
2+LC2029; HT-29+ slp2; HT-29+ LC2029. 
#
p< 0.001 adhesion of S. enteritidis to Caco-2 or HT-29 cells vs. 
adhesion of S. enteritidis to Caco-2+ Slp2; Caco- 2+LC2029; HT-29+ slp2; HT-29+ LC2029. 
χ
p<0.001 
adhesion of E. coli 0157:H7 to Caco-2 or HT-29 cells vs. adhesion of E. coli 0157:H7 to Caco-2+ Slp2; 
Caco- 2+LC2029; HT-29+ slp2; HT-29+ LC2029. All data were representative of six independent 
experiments, tested in triplicate.  
 
Table 5. Co-aggregative abilities of vaginal LC2029 strain with foodborne pathogens.  
Strain of lactobacilli Co-aggregation with: 
Campylobacter jejuni ATCC 
33291 
Salmonella enteritidis ATCC 
25928 
Escherichia coli 0157:H7 
ATCC 43889 
L. crispatus 2029 + + + + + + + + + + 
L. crispatus 2029* 0 0 0 
L. crispatus 1385** 0 0 0 
Number of + symbols illustrate degree of co-aggregation. 
*
LC2029 strain after removal of the Slp2 from the 
cell surface by LiCl; 
**
Slp-negative vaginal LC1385 strain. All data were representative of six independent 















Table 6. Antagonistic activity of Spl2 and LC2029, LC2029
#
, LC1385 strains to foodborne pathogens.   
Target bacteria Inhibition zone values (mm) Mean ± SEM 
Antagonist 
Slp2 LC 2029  LC2029
#
 LC 1385 
Campylobacter jejuni ATCC 33291 0 13.5 ± 1.7* 11.8 ± 0.9* 2.2 ± 0.8 
Salmonella enteritidis ATCC 25928 0 12.9 ± 1.8* 11.5 ± 1.4* 2.1 ± 0.6 
Escherichia coli 0157:H7  0 14.6 ± 1.2* 13.8 ± 1.3* 2.4 ± 0.5 
LC2029
# 
strain after removal of Slp2 from the cell surface by LiCl; *
 
p< 0.05 LC2029 and LC2029
# 
strain 










 , LC1385 strains. 















LC2029 118 ± 6 p>0.05  
LC2029
# 
  115 ± 7   
LC1385 9 ± 1  p<0.001 
LC2029
# 
strain after removal of Slp2 from the cell surface by LiCl; values represent means and SEM from 
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